Европейский союз - датский - EMA (European Medicines Agency)

mylan ireland limited - fingolimod hydrochlorid - multipel sklerose, recidiverende-remitterende - immunosuppressiva - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 og 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Европейский союз - датский - EMA (European Medicines Agency)

takeda pharma a/s - vedolizumab - colitis, ulcerative; crohn disease - selektive immunosuppressiva - colitis colitisentyvio er indiceret til behandling af voksne patienter med moderat til svær aktiv colitis ulcerosa, der har haft et utilstrækkeligt respons med, tabt svar på, eller var intolerante til enten konventionel behandling eller en tumor nekrose faktor alfa (tnfa) antagonist. crohns diseaseentyvio er indiceret til behandling af voksne patienter med moderat til svær aktiv crohns sygdom, der har haft et utilstrækkeligt respons med, tabt svar på, eller var intolerante til enten konventionel behandling eller en tumor nekrose faktor alfa (tnfa) antagonist. pouchitisentyvio is indicated for the treatment of adult patients with moderately to severely active chronic pouchitis, who have undergone proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis, and have had an inadequate response with or lost response to antibiotic therapy.

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - ifosfamid - pulver til injektions-/infusionsvæske, opløsning - 500 mg

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - cyclophosphamid, vandfrit - overtrukne tabletter - 50 mg

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - cyclophosphamid, vandfrit - pulver til injektionsvæske, opløsning - 200 mg

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - cyclophosphamid, vandfrit - overtrukne tabletter - 50 mg

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - cyclophosphamid, vandfrit - pulver til injektionsvæske, opløsning - 1 g

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - cyclophosphamid, vandfrit - pulver til injektionsvæske, opløsning - 200 mg

Европейский союз - датский - EMA (European Medicines Agency)

mylan ireland limited - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Европейский союз - датский - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.